ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01349049
Recruitment Status : Completed
First Posted : May 6, 2011
Last Update Posted : April 6, 2018
Sponsor:
Information provided by (Responsible Party):
Plexxikon

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2018
  Actual Study Completion Date : March 2018